Anika Therapeutics reported $46.97M in Current Liabilities for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acceleron Pharma XLRN:US $ 49.82M 10.34M
Acorda Therapeutics ACOR:US $ 133.05M 4.2M
Adamas Pharmaceuticals ADMS:US 34.87M 3.38M
Agenus AGEN:US $ 138.37M 8.49M
Agios Pharmaceuticals AGIO:US $ 96.5M 2.11M
Anika Therapeutics ANIK:US $ 46.97M 10.11M
Arrowhead Research ARWR:US $ 167.19M 142.09M
Clovis Oncology CLVS:US $ 173.24M 11.69M
Dicerna Pharmaceuticals DRNA:US $ 182.15M 4.21M
Enanta Pharmaceuticals ENTA:US $ 26.62M 3.57M
Halozyme Therapeutics HALO:US $ 421.38M 394.41M
Heron Therapeutics HRTX:US $ 100.92M 1.59M
Immunogen IMGN:US $ 122.32M 22.5M
Insmed INSM:US $ 81.4M 37.41M
Integra Lifesciences IART:US $ 412.3M 11.29M
Johnson & Johnson JNJ:US $ 40932M 1561M
Karyopharm Therapeutics KPTI:US $ 62.01M 1.8M
Ligand Pharmaceuticals LGND:US $ 95.8M 4.31M
Macrogenics MGNX:US $ 53.04M 2.37M
Merit Medical Systems MMSI:US $ 207.68M 22.67M
Rigel Pharmaceuticals RIGL:US $ 52.02M 11.18M
Sangamo Biosciences SGMO:US $ 132.84M 10.71M
Stryker SYK:US $ 3953M 1088M
Surmodics SRDX:US $ 15.7M 3.25M
Veracyte VCYT:US $ 16.78M 2.86M
Xencor XNCR:US $ 99.93M 21.13M